Quality Of Life Outcomes clinical trials

Explore recruiting quality of life outcomes clinical trials.

Recruiting quality of life outcomes studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Quality Of Life Outcomes trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PROgnostic value of precision medicine in patients with Myocardial Infarction and non-obStructive coronary artEries: the PROMISE study

Italy

Therapeutic use (Phase IV) EU CTIS Study details

A randomized, double-blind, placebo-controlled clinical trial evaluating the efficacy and quality of life outcomes of Vi-Siblin in patients with low anterior resection syndrome following rectal cancer surgery.

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

Effect of neoadjuvant Degarelix on MRI-guided transurethral ultrasound ablation in patients with intermediate-risk prostate cancer: A pilot study

Finland

Human Pharmacology (Phase I)- Other EU CTIS Study details

Itraconazole (ITRA) with standard radiotherapy (RT) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma multiforme (GBM) ITRA-RAD: Phase I Clinical Study

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

A randomized trial comparing conventional "salvage" radiotherapy and individualized PSMA-PET/CT targeted treatment in patients with biochemical recurrence after prostate cancer surgery

Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase III Randomised, Double-Blind, Placebo-Controlled, Multicentre Study of Durvalumab in Combination with Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib in Newly Diagnosed Advanced Ovarian Cancer Patients (DUO-O).

Belgium, Italy, Spain, France, Finland, Bulgaria +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Quality Of Life Outcomes trials by city

Quality Of Life Outcomes in Toronto Quality Of Life Outcomes in Vancouver Quality Of Life Outcomes in Montreal Quality Of Life Outcomes in Calgary Quality Of Life Outcomes in Edmonton Quality Of Life Outcomes in Ottawa Quality Of Life Outcomes in Winnipeg Quality Of Life Outcomes in Quebec City Quality Of Life Outcomes in Hamilton Quality Of Life Outcomes in Kitchener Quality Of Life Outcomes in London Quality Of Life Outcomes in Halifax Quality Of Life Outcomes in New York Quality Of Life Outcomes in Los Angeles Quality Of Life Outcomes in Chicago Quality Of Life Outcomes in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease